secwatch.observer — SEC 8-K summary
======================================

Issuer:     PAVmed Inc. (PAVM)
CIK:        0001624326
Form:       8-K
Filed at:   2024-11-21T23:59:59+00:00
Accession:  0001493152-24-047156
Event type: debt
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

PAVmed exchanges $22.3M convertible notes for Series C Preferred Stock and enters separate $2.65M purchase
--------------------------------------------------------------------------------

- Exchanged $22,347,543 principal amount of Senior Secured Convertible Notes for 22,347 shares of Series C Preferred Stock.
- Series C Preferred Stock carries 7.875% annual dividend, convertible at $1.068 per share, and redeemable at 132.5% of stated value.
- Company will seek stockholder approval by Jan 31, 2025 to increase authorized common stock from 50M to 250M shares.
- Separate Securities Purchase Agreement for $2,652,456.76 of unsecured debt cancelled in exchange for 2,653 additional Series C Preferred shares.
- Outstanding convertible note balance reduced to approximately $6.4 million after exchange; remaining note maturity extended to Dec 31, 2025.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1624326/000149315224047156/0001493152-24-047156-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1624326/000149315224047156/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-047156

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer